A new review of research was published in the Journal of Primary Care & Community Health (2022) which examined the literature on the use of cannabis products on sleep, including an overview of cannabis and related psychoactive compounds, the current state of the law as it pertains to the prescribing and use of these substances, and potential side effects and drug interactions.
The current science shows that cannabis products have minimal to no effects on sleep disorders and may have deleterious effects in some individuals.
Withdrawal from the use of cannabis can lead to significant sleep disruption and relapse to cannabis use.
Furthermore, cannabis products can result in daytime sleepiness and impair driving capacity.
The concerns with the use of OTC CBD products pertain to the overall lack of evidence that these help with sleep, possible drug interactions, and contamination with Δ9-THC with its attendant psychoactive effects as well as the potential for dependence and other side effects.
Prevention professionals and organizations should inform youth and adults of the lack of evidence supporting cannabis products for improving sleep, present risks of using cannabis products, and provide healthy alternatives and strategies for improving sleep.Read the entire research review paper: https://journals.sagepub.com/doi/full/10.1177/21501319221081277